Compounding & Clinic Insights — MedClinic Partners Blog
Blog
Compliance and supply guidance for clinics and 503A pharmacies
503A vs. 503B Supply: What Clinics Need to Know Before Ordering Compounded GLP-1s
The 503A and 503B pathways are not interchangeable. Understanding the difference determines which supply partners your clinic can legally work with in 2026.
How Do Clinics Get Started with a 503B Supply Partner?
Getting connected with a vetted 503B supply partner involves more than placing an order. Here is the step-by-step process for clinics looking to establish a compliant supply relationship.
How to Activate a Backup 503A Supplier Overnight When Your Pharmacy Runs Out
When your primary 503A pharmacy goes on backorder, you have a 7-day window before patients start leaving. Here is the exact playbook for activating a backup supplier fast enough to keep every patient on protocol.
What Are the FDA Rules on BUD for Sterile Compounded Drugs?
The FDA and USP set specific rules for beyond-use dates on sterile compounded drugs. Here is what the current framework requires and how it affects clinics and pharmacies.
NAD+ Therapy for Georgia Clinics: Supply & Provider Guide
Georgia medical practices offering NAD+ subcutaneous injections need a reliable cGMP supply partner. Here is what Georgia providers need to know about ordering NAD+ for their clinic.
NAD+ Injections for Arkansas Medical Practices: A Provider Guide
Arkansas clinics offering NAD+ subcutaneous injections need a reliable cGMP supply partner. Here is what Arkansas providers need to know about ordering NAD+ for their practice.
When (and How) to Switch Your 503A Compounding Supplier
Back-orders, missing COAs, compliance gaps — here are the signs it is time to switch your 503A compounder, and how to make the transition without disrupting patient care.
How Supply Disruptions Kill Patient Retention in GLP-1 Programs
A single supply disruption can cost your clinic tens of thousands in lost patient revenue. Here is the data on how backorders drive patient churn — and the one operational change that prevents it.
Compounded GLP-1 Supply for Arkansas Medical Practices
Arkansas clinics ordering compounded semaglutide and tirzepatide need a vetted 503A/503B supply partner. Here is what Arkansas providers need to know about access and compliance.
GLP-1 Supply Chain: What Every Clinic Needs to Know in 2026
The GLP-1 supply chain is more complex — and more regulated — than most providers realize. Here is what your clinic needs to understand before placing your next order.
How Long Does Compounded Semaglutide Last After Reconstitution?
The shelf life of compounded semaglutide after reconstitution depends on the formulation, diluent, and storage conditions. Here is what clinics need to know.
NAD+ Therapy for Wisconsin Clinics: Supply & Provider Guide
Wisconsin medical practices offering NAD+ subcutaneous injections need a reliable cGMP supply partner. Here is what Wisconsin providers need to know about ordering NAD+ for their clinic.